75 results
Page 3 of 4
PREC14A
3mf0sdrn0127dond
8 Apr 22
Preliminary proxy with contested solicitation
4:21pm
DEFA14A
m191on 4xs3rp77j
5 Apr 22
Additional proxy soliciting materials
5:03pm
PREC14A
0ck4ddi91ag
30 Mar 22
Preliminary proxy with contested solicitation
5:23pm
DEFA14A
se7mp usfan
30 Mar 22
Additional proxy soliciting materials
4:00pm
DEFA14A
hmfas9p6c q702w
28 Mar 22
Additional proxy soliciting materials
5:31pm
8-K
EX-99.1
zf86w76v0mr9ewr54x
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
EX-99.1
qrhhplzyb5dlfmlt yp8
21 Mar 22
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors
7:21am
8-K
EX-99.1
ntpqulxlpn1
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
S-3
b7j61ldxea 34ey
15 Nov 21
Shelf registration
4:06pm
8-K
EX-99.1
cl55 lknkb
10 Nov 21
Athira Pharma Reports Third Quarter 2021 Financial Results and Business Update
4:11pm
8-K
EX-99.1
3b24xa2fumu
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
EX-10.1
xvrd2
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
EX-99.1
32xv6hq 81hlag
16 Aug 21
Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update
4:11pm
8-K
EX-99.1
hzz0ceik9o
17 Jun 21
Departure of Directors or Certain Officers
9:32pm
8-K
EX-99.1
d4qk2
13 May 21
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights
4:10pm
8-K
EX-99.1
0arkhgsoh mkhx0a
25 Mar 21
Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
12:00am